• GmMKK4–GmMPK6–GmERF113 Cascade Drives Soybean Resistance

  2026-05-13

  This study elucidates a phosphorylation-dependent MAPK signaling cascade—comprising GmMKK4, GmMPK6, and GmERF113—that enhances soybean resistance to Phytophthora sojae. The findings provide mechanistic insights into plant disease resistance and offer new molecular targets for crop improvement.

• TMSB10 UTR Boosts SARS-CoV-2 mRNA Vaccine Immunogenicity

  2026-05-12

  Ding et al. (2024) demonstrate that employing the untranslated region (UTR) from TMSB10 significantly enhances both in vitro and in vivo expression of mRNA vaccine antigens, leading to stronger humoral and cellular immune responses against SARS-CoV-2. Their work highlights the importance of rational UTR selection in mRNA vaccine design, with implications for optimizing antigen presentation and adaptive immunity.

• Pifithrin-α: Applied Workflows for p53-Dependent Apoptosis I

  2026-05-12

  Leverage Pifithrin-α for precise p53 inhibition in apoptosis, ferroptosis, and neuroprotection assays. This guide translates novel experimental findings into actionable protocols, troubleshooting, and workflow enhancements for researchers seeking robust p53 pathway control.

• Abiraterone Acetate: CYP17 Inhibitor Workflows in PCa Resear

  2026-05-11

  Abiraterone acetate, a potent CYP17 inhibitor, enables sophisticated modeling of androgen biosynthesis suppression in prostate cancer research—especially within 3D spheroid platforms. This article details practical workflows, protocol optimization, and troubleshooting for effective use in translational and mechanistic studies.

• KPT330 Enhances Precision of Cas9 Genome Editing via mRNA Ex

  2026-05-11

  The referenced study demonstrates that the FDA-approved drug KPT330, a selective inhibitor of nuclear export, can improve the specificity of CRISPR-Cas9 genome and base editing by selectively modulating the nuclear export of Cas9 mRNA. This mechanism provides a new strategy for indirectly controlling Cas9 activity, reducing off-target effects, and expanding the toolkit for high-fidelity genome engineering.

• MK-0812 in MASH Models: Deep Mechanisms and Translational Im

  2026-05-10

  Explore MK-0812 as a potent monocyte trafficking inhibitor in metabolic dysfunction-associated steatohepatitis (MASH) research. This article provides a technical, mechanism-focused analysis and practical protocol guidance, uniquely bridging reference findings and assay design.

• ARCA Cy5 EGFP mRNA (5-moUTP): Precision in mRNA Delivery Ass

  2026-05-09

  ARCA Cy5 EGFP mRNA (5-moUTP) combines 5-methoxyuridine modification with dual fluorescence for accurate, real-time tracking of mRNA delivery, translation, and localization in mammalian cells. Its streamlined workflow, immune evasion, and direct-readout capabilities set a new benchmark for quantitative mRNA delivery system research.

• SARS-CoV-2 Nucleocapsid Protein Suppresses GADD34 Pathway

  2026-05-08

  This study uncovers how the SARS-CoV-2 nucleocapsid protein antagonizes the GADD34-mediated innate immune pathway by inducing atypical stress granule-like foci. The findings elucidate a novel viral immune evasion mechanism, providing a framework for further research on viral-host interactions and potential therapeutic strategies.

• Microfluidic Peptide/mRNA Complexes Enable Pulmonary Deliver

  2026-05-08

  This study introduces a microfluidic mixing approach to generate robust peptide/RNA complexes, enabling efficient pulmonary delivery of mRNA and siRNA via nebulisation. The findings demonstrate that cationic peptide-based vectors maintain transfection efficiency and structural integrity through aerosolisation, offering a promising non-viral alternative for lung-targeted RNA therapeutics.

• α-Amanitin: Precision RNA Polymerase II Inhibition in Resear

  2026-05-07

  α-Amanitin is a highly specific inhibitor of eukaryotic RNA polymerase II, making it indispensable for transcriptional regulation research and gene expression pathway analysis. As supplied by APExBIO (SKU A4548), its stability, potency, and precise action facilitate reproducible results in cell-based and developmental studies.

• SAR405: Precision Vps34 Inhibitor for Autophagy Research

  2026-05-07

  SAR405 enables highly selective, nanomolar-range inhibition of Vps34, making it the gold standard for dissecting autophagy and vesicle trafficking in cell biology and disease modeling. Its exquisite specificity and compatibility with diverse workflows set it apart for advanced mechanistic studies.

• Patient-Derived 3D Spheroids: A Translational Model for Pros

  2026-05-06

  This study introduces patient-derived three-dimensional spheroid cultures from radical prostatectomy tissue as a robust and versatile in vitro model for organ-confined prostate cancer. The model enables long-term viability, recapitulates tumor heterogeneity, and supports pharmacological testing, providing a significant advance for translational prostate cancer research.

• Moxidectin Potentiates Polyene Antifungals Against Oral Cand

  2026-05-06

  This study reveals that moxidectin elevates ergosterol biosynthesis in Candida albicans, thereby enhancing the antifungal efficacy of polyenes such as nystatin and amphotericin B. These findings offer a mechanistically grounded strategy to overcome certain limitations of current polyene treatments in oral candidiasis and highlight new opportunities for combination therapy.

• Dual-Action p38α MAPK Inhibitors Accelerate Dephosphorylatio

  2026-05-05

  This study uncovers how certain p38α MAPK inhibitors not only block kinase activity but also enhance phosphatase-mediated dephosphorylation by stabilizing a unique activation loop conformation. The findings reveal a new dual-action mechanism with potential to improve specificity and potency in kinase-targeted research and therapeutic strategies.

• Cyclo (-RGDfC): Precision Tumor Targeting in Cell Assays

  2026-05-05

  Cyclo (-RGDfC) delivers robust, integrin αvβ3-specific targeting for advanced cancer and angiogenesis research. Its cyclic structure confers unmatched stability and specificity, enabling high-fidelity cell adhesion, migration, and drug delivery workflows. Discover how APExBIO’s peptide empowers reproducible, data-driven experimental design.

16145 records 1/1077 page Next 12345 下5页 Last page